Catecholamines and the sleep-wake cycle I. EEG and behavioral arousal
- 5 April 1982
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 30 (14), 1145-1157
- https://doi.org/10.1016/0024-3205(82)90656-7
Abstract
The exact role of catecholamines (CA) on the sleep-wake cycle is still controversial. Critical analysis of lesion studies tends to suggest a neuromodulatory role for both dopamine (DA) and norepinephrine (NE) on EEG and behavioral arousal. Support for this view is provided by pharmacological studies in which catecholaminergic systems are activated or inhibited. Taken together they show that disturbances in the dynamic balance between neurochemical systems may alter the conditions for wake-triggering mechanisms to express at optimal levels. Large electrolytic or neurotoxic lesions which affect noradrenergic and dopaminergic structures are associated with marked and prolonged EEG changes and decreased behavioral arousal, respectively. In contrast, specific and circumscribed damage restricted to these systems is followed by a transient decrease in waking activity. Thus, results observed after large central lesions are most probably related to destruction of non-catecholaminergic neurons. Inhibition of brain CA synthesis causes behavioral sedation and a decrease in waking activity. Selective pharmacological stimulation of presynaptic alpha-adrenergic (∝ 2) receptors tends to decrease waking, while opposite effects result from ∝2-receptor blockade. Drugs with agonistic activity at postsynaptic alpha-adrenergic (∝1) sites increase EEG desynchronization, but specific blockade of ∝1-receptor does not result in marked decreases of waking EEG. In contrast, treatments which simultaneously block NE and DA receptors significantly affect waking. Beta-adrenergic receptor blockers show no conclusive effects on waking or sleep. Selective DA-receptor agonists induce biphasic effects, with low doses decreasing and large doses increasing cortical desynchronization and motility. Opposite effects are observed in laboratory animals after injection of specific DA-receptor blockers.Keywords
This publication has 93 references indexed in Scilit:
- Biphasic effects of pimozide on sleep-wakefulness in dogsLife Sciences, 1980
- Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: Effect of nicotine in a low concentrationLife Sciences, 1979
- Effects of bromocriptine and α-flupenthixol on sleep in REM sleep deprived ratsLife Sciences, 1979
- Evidence for central alpha adrenoceptor stimulation as the basis of paradoxical sleep suppression by alpha methyldopaNeuroscience Letters, 1978
- Paradoxical sleep inhibition by central alpha-adrenoceptor stimulant clonidine antagonized by alpha-receptor blocker yohimbineLife Sciences, 1977
- Evidence for dopamine receptors in the human brain mediating sedation and sleepLife Sciences, 1977
- Effect of the norepinephrine receptor stimulating agent ?clonidine? on the turnover of 5-hydroxytryptamine in some areas of the rat brainJournal of Neural Transmission, 1975
- Differential effects of D- and L-amphetamine on the sleep of depressed patientsLife Sciences, 1975
- Effect of 6-Hydroxydopamine on behaviour and cerebral amine content in ratsCellular and Molecular Life Sciences, 1969
- Measurement of hyperactivity in rats in a dose-response-curve after intrahypothalamic norepinephrine injectionLife Sciences, 1969